Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 11, 2026 05:00 ET | Source: AKAMPION

EMA Grants PRIME Designation to TolerogenixX’s MIC-Lx Therapy for Donor-Specific Immune Tolerance in Kidney Transplantation

TolerogenixX´ MIC therapy receives EMA PRIME designation; up to 10-year follow‑up data support sustained safety and reduced immunosuppression
March 10, 2026 07:00 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals Announces Orphan Drug Designation Granted to Tegoprubart for the Prevention of Allograft Rejection in Liver Transplantation

Eledon Pharmaceuticals Announces Orphan Drug Designation Granted to Tegoprubart for the Prevention of Allograft Rejection in Liver Transplantation
March 04, 2026 16:05 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals to Participate in Leerink Partners 2026 Global Healthcare Conference

Eledon Pharmaceuticals to Participate in Leerink Partners 2026 Global Healthcare Conference
February 26, 2026 09:00 ET | Source: Paragonix Technologies, Inc.

Paragonix Technologies President Lisa Anderson Named a 2026 CNBC Changemaker

Anderson recognized among 50 women leaders transforming industries, honored for advancing organ preservation through innovation, global expansion, and a landmark acquisition Dr. Lisa Anderson named...
February 05, 2026 16:10 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026

Eledon Pharmaceuticals to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
February 05, 2026 09:00 ET | Source: Paragonix Technologies, Inc.

Paragonix KidneyVault® System Enables Reallocation of Donor Kidney After Late Decline and Extended Ischemic Time

WALTHAM, Mass., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Paragonix Technologies, a pioneer in organ transplant technologies and services, today announced a donor kidney case in which the Paragonix...
January 23, 2026 07:00 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals Presents Long-Term Phase 1b Data for Tegoprubart in Kidney Transplant Patients at the American Society of Transplant Surgeons Winter Symposium

Eledon Pharmaceuticals Presents Long-Term Phase 1b Data for Tegoprubart in Kidney Transplant Patients at ASTS
January 08, 2026 16:05 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2026 Outlook

Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2026 Outlook
December 16, 2025 09:00 ET | Source: Paragonix Technologies, Inc.

Paragonix Announces Europe’s First-in-Human Use of BAROguard® Donor Lung Preservation System by Leading Belgian Transplant Center

WALTHAM, Mass., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Paragonix Technologies, a leader in advanced organ transplant preservation and organ procurement services, announced today that University Hospitals...
December 09, 2025 09:00 ET | Source: Paragonix Technologies, Inc.

Two-Year Cardiac Study Published in JHLT Reveals Long-Term Survival Benefits with Advanced Heart Preservation

WALTHAM, Mass., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Paragonix Technologies, a pioneer in organ transplant technologies and services, announced today the publication of groundbreaking research on...